Metformin Regulates the Inflammatory Response of Human Macrophages to Mycobacterium tuberculosis Through a Reduction of M1 Polarization

Angel Sanca, Jose Barragan, Piya Kositangool, Javier Vargas-Medrano, Valeria Diaz-Pacheco, Aleli Campbell, Bharathi S. Gadad, Jorge L. Cervantes

Abstract


Background: Besides its ability to control hyperglycemia, metformin (MTF) has effects on macrophage and lymphocyte functions, improving control of Mycobacterium tuberculosis (Mtb) infection and decreasing disease severity. We aimed to better understand the effects of MTF on human macrophages’ response to Mtb.

Methods: Phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 cells were treated with 2 mM of MTF for 4 h, and then inoculated with Mtb from various lineages. Since MTF can also directly inhibit key metabolic processes of Mtb, we utilized γ-irradiated mycobacteria. Phagocytosis was assessed by immunofluorescent assay. Supernatants were tested with a multiplex enzyme-linked immunosorbent assay (ELISA) system.

Results: Phagocytosis of all Mtb strains was increased in MTF-treated macrophages. A diminished nuclear factor-kappa B (NF-κB) activation after Mtb stimulation was observed in MTF-treated macrophages. There was no effect on interferon regulatory factor (IRF) activation by MTF pretreatment. Results from the multiplex ELISA showed a modulatory effect by MTF on the secretion of various pro-inflammatory cytokines, with no effect on anti-inflammatory cytokines. Reduction in the expression of M1 polarization markers was observed in MTF-treated cells upon Mtb stimulation.

Conclusions: Our results indicate that MTF improves phagocytosis of Mtb by macrophages, while at the same time modulating their inflammatory response. This occurs through a downshift of M1 polarization. Excessive inflammation is a phenomenon associated with active tuberculosis (TB) and with disruption of the granuloma architecture. MTF treatment could allow for an improved response of macrophages to Mtb infection. These results support the effects of MTF in key steps of Mtb infection control, and support its use as an additional treatment for TB.




Clin Infect Immun. 2021;6(2):40-46
doi: https://doi.org/10.14740/cii130

Keywords


Metformin; Mycobacterium tuberculosis; Macrophage polarization; Phagocytosis

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

AI in Clinical Medicine

Current Translational Medicine

Current Public Health and Epidemiology

Ophthalmology and Eye Health

Clinical Research of Dermatology

Food Sciences and Clinical Nutrition

Current Psychiatry and Mental Health

Current Emergency Medicine

Journal of Current Pharmacology

Current Dentistry and Oral Health

Current Research of Life Sciences

Journal of Sports Medicine Research

Journal of Minimally Invasive Medicine

Plastic Surgery and Aesthetic Medicine

Clinical Geriatric Medicine

Current Occupational Medicine

Journal of Current Surgery, quarterly, ISSN 1927-1298 (print), 1927-1301 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.currentsurgery.org   editorial contact: editor@currentsurgery.org    elmer.editorial2@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.